Ask AI
ProCE Banner Activity

Innovation Without Access Is Not Progress: An Advocate’s Reflections From AIDS 2026

Conference Coverage
Clinical Thought

As a person living with HIV, I left Rio de Janeiro thinking less about what science can achieve and more about who will actually benefit from it. Here’s why equity needs to be built into the development, licensing, and delivery of new technologies from the outset.

Released: August 27, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported through independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

International AIDS Society

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Financial Disclosures

Primary Author

Gastón Devisich has no relevant financial relationships to disclose.